A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy

With the increasing global burden of dyslipidemia over the past 30 years, it is estimated that more than 200 million people worldwide are under statin therapy. In India, roughly 25–30% of urban populations and 15–20% of rural populations have abnormal lipid levels. Statin, which is deemed to be the...

Descripción completa

Detalles Bibliográficos
Autores principales: Needamangalam Balaji, Jyotsna, Prakash, Sreenidhi, Joshi, Ashish, Surapaneni, Krishna Mohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326747/
https://www.ncbi.nlm.nih.gov/pubmed/35892446
http://dx.doi.org/10.3390/clinpract12040060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326747/
https://www.ncbi.nlm.nih.gov/pubmed/35892446
http://dx.doi.org/10.3390/clinpract12040060

Ejemplares similares